The business world has always fascinated me and being an active part of CPHoldings means I can use my knowledge and energy to support high-growth businesses. The best example of where this partnership was most prevalent was with Establishment Labs Holdings Inc. Backed by CPH, Establishment Labs Holdings Inc. started trading on the Nasdaq Stock Market under the trading symbol “ESTA” following its initial public offering.

Established Labs Holdings Inc. is a global medical technology company focused on improving patient safety and aesthetic outcomes. Initially, in the breast aesthetics and reconstruction market, they design, develop, manufacture and market an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica and currently sold in over 60 countries through exclusive distributors or a direct sales force. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA to initiate the Motiva Implant® clinical trial in the United States. In addition to Motiva Implants®, Establishment Labs’ product and technologies portfolio include Divina® 3D Simulation System, Puregraft, and MotivaImage® Centers.

“The listing on Nasdaq represented a significant milestone for Establishment Labs and our shareholders,” said Mr. Chacón-Quirós. “It was a true honor to be the first company headquartered in Costa Rica to be listed on a major stock exchange in the United States.”

To see the team and Mr. Chacón-Quirós’ family welcomed into the Nasdaq family was unbelievable and to hear, Joe Brantuk, Vice President of Nasdaq say how much he “looked forward to supporting their continued success in improving patient safety and aesthetic outcomes while simultaneously working towards its entry into the U.S. market” meant a great deal to everyone.